Outcomes of EVAR in Hemodynamically Stable and Unstable Patients with Ruptured AAA: A Prospective Analysis  by Mehta, Manish et al.
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February 2011554 Abstractspraceliac aorta, superior mesenteric artery, renal arteries, and iliac artery
bifurcation. Median oral examination scores were 5% vs 87%, 26% vs 94%,
19% vs 86%, 30% vs 88%, and 29% vs. 87%, respectively (all P  .001) and
median or scores were 1.1 vs 2.9, 1.3 vs 3.5, 1.2 vs 3.2, 1.2 vs 3, and 1.5 vs
3.9, respectively (all P  .001).
Conclusions: Fresh cadaver laboratory sessions can provide a learner-
centered and safe environment for acquiring procedural understanding and
operative confidence of complex vascular exposures and allow for transfor-
mational change that is essential to becoming a competent vascular surgeon.
Osteoprotegerin Serum Levels in Abdominal Aortic Aneurysm
Vladislav Treska, Professor of Surgery, Ondrej Topolcan, Professor, Jindra
Vrzalova, Mgr, Jiri Molacek, Ass. Prof, Karel Houdek, MD, University
Hospital, Plzen, Czech Republic.
Objectives: Serum levels of osteoprotegerin (OPG) are a significant
marker for the prediction of cardiovascular disease severity and patient
mortality. Its association with abdominal aortic aneurysm (AAA) is still a
matter of discussion. The aim of our prospective nonrandomized study was
to find if any correlation existed between serum levels of OPG and AAA.
Methods: In 43 patients operated on for AAA, venous (peripheral
blood samples before operation) and arterial OPG serum levels (aneurysm
blood samples during open surgery) were evaluated by multiplex immuno-
analytic assay (xMAP) technology. Plasma OPG levels were correlated with
age, gender, diameter, and symptoms of AAA, hypertension, smoking,
diabetes mellitus, carotid artery stenoses, peripheral arterial stenoses, or
occlusions and AAA wall thrombus in multifactorial analysis. Twenty pa-
tients operated on for hernia served as a control group.
Results: OPG plasma levels were 1000 times higher in the AAA group
compared with controls. VenousOPG plasma levels were directly dependent
on AAA diameter (P  .01) and symptoms (P  .0005). Other important
factors for OPG plasma levels were smoking (P  .01) and age (P  .05).
Arterial plasma levels of OPG were significantly higher compared with
venous levels. Factors significant for arterial OPG plasma levels were age (P
 .01), hypertension (P  .05), and smoking (P  .03).
Conclusions: OPG venous levels are related to diameter and symptoms
of AAA. OPG should be used as a predictor of AAA growth in small AAAs
and also as a predictor of imminent AAA rupture. OPG is also a marker of
cardiovascular risk in smokers, diabetic patients, and those with carotid
artery stenosis, which is important for the type of operating procedure
decision making.
Interpreting the EVAR versus OPEN Repair Randomized Trials:
A Critical Meta-Analysis
Caron Rockman, MD, Maya Rubin, BA, Mark A. Adelman, MD, Frank
Veith, MD, Jeffrey S. Berger, MD, New York University Medical Center,
New York, NY.
Objectives: Although endovascular aneurysm repair (EVAR) has lower
perioperative mortality than open aortic aneurysm repair (OPEN), its ben-
efits may be compromised by an increase in secondary interventions and a
possible increase in late mortality. The goal of this study was to explore these
findings by performing an analysis of randomized controlled trials (RCTs)
comparing the outcomes of EVAR and OPEN.
Methods: A meta-analysis of RCTs comparing EVAR with OPEN was
performed, encompassing 2484 patients. Outcome measures included all-
cause mortality (early, late, total), AAA-related mortality (early, late, total),
graft-related complications, and secondary interventions.
Results: A total of 349 deaths (28.1%) occurred among 1243 EVAR
patients, and 367 deaths (29.6%) among 1241 OPEN patients. EVAR was
associated with a significant benefit in early all-cause mortality (1.3% vs
4.7%), with an odds ratio (OR) of 0.27 (95% confidence interval [CI],
0.15-0.49; P  .001). However, no significant differences were noted for
late all-cause mortality (OR, 1.04; 95% CI, 0.86-1.27; P  .67), or total
all-cause mortality (OR, 0.93; 95% CI, 0.77-1.12; P  .43). EVAR was
associated with a significant reduction in early AAA-related mortality (1.4%
vs 4.0%; OR, 0.36; 95% CI, 0.20-0.63; P .001). However, EVARwas also
associated with a significant increase in late AAA-related mortality (2.2% vs
0.9%; OR, 2.25; 95% CI, 1.11-4.56; P  .03). There was no significant
difference noted for total AAA-related mortality (3.5% vs 4.9%; OR, 0.73;
95% CI, 0.49-1.09; P  .13). EVAR was associated with a significant
increase in graft-related complications (40.1% vs 10.5%; OR, 6.01; 95% CI,
4.59-7.89, P  .001), and secondary interventions (19.2% vs 10.1%; OR,
2.12; 95% CI, 1.67-2.69; P  .001).
Conclusions: In pooled analysis of the RCTs comparing EVAR and
OPEN, EVAR has clear advantages of decreased early AAA-related and
all-cause mortality. Although the success of EVAR in reducing late AAA-
related mortality may be suboptimal, the importance of decreased early
mortality cannot be minimized, particularly from the patient’s perspective.
Future work must focus on improvements in design and techniques that will
decrease device-related complications and the need for secondary interven-
tions to further improve the long-term success of EVAR. Despite these
v
2ssues, EVAR remains the procedure of choice in anatomically suitable AAA
atients.
otally Robotic Aortic Surgery versus Robotic-Assisted Aortic Surgery
ith Mini-Laparotomy
udith C. Lin, MD, Sanjeev A. Kaul, MD, Akshay Bhandari, MD, James O.
eabody, MD, Mani Menon, MD, Henry Ford Hospital, Detroit, Mich.
Objectives: Safety and efficacy of totally laparoscopic aortic surgery and
aparoscopic-assisted aortic surgery with minilaparotomy have been demon-
trated in previous studies. Published reports of robotic-assisted aortic
urgery involve a combination of laparoscopy for aortic dissection and
obotic system for vascular reconstruction. The objective of this study is to
etermine the feasibility and advantage of a totally robotic aortic dissection
nd vascular reconstruction versus robotic-assisted aortic procedures for
ortoiliac occlusive disease (AIOD) and abdominal aortic aneurysm (AAA).
Methods: From February 2006 to August 2010, 21 patients were
elected for robotic aortic procedures: 12 had aortobifemoral bypass, 6 had
AA repairs, 1 had iliac aneurysm repair, and 2 had ligation of type II
ndoleak after endovascular aneurysm repair. Inclusion criteria included
AA 5 cm, iliac aneurysm 3 cm, and AIOD TransAtlantic InterSociety
onsensus C or D. The daVinci S Surgical System was used for the aortic
issection in all cases and the aortic anastomosis in three. Institutional
eview Board approval and informed consent were obtained.
Results: The 21 patients (6 women, 15 men) were an average age of
5.7 years (range, 44-86 years) and body mass index of 27.23 kg/m2, and
0.4% were American Society of Anesthesiology 3 or 4. Twenty patients
95.2%) underwent successful robotic dissection of the abdominal aorta.
ne patient underwent full conversion to open AAA repair due to trocar
njury. Of the remaining 20 patients, the average robotic dissection of the
nfrarenal aorta was 113.1 minutes and average aortic clamp time was 86
inutes. Procedures in 15 patients were performed with a minilaparotomy
sing an average abdominal incision of 13 cm to implant the Dacron or
TFE graft. Five patients underwent a totally robotic procedure with robotic
ortic reconstruction or ligation of type II endoleak. Thirty-day survival rate
as 100%. Median length of stay (LOS) was 7.5 days. All grafts were patent
ith a median follow-up of 26.5 months.
Conclusions: In this selected group of patients, totally robotic aortic
urgery for aortic dissection and vascular reconstruction is feasible. For aortic
rocedures completed total robotically without an abdominal incision, the
stimate blood loss was significantly less than robotic-assisted procedures
ith minilaparotomy.
able. Totally robotic versus robotic-assisted aortic
rocedures
Aortic clamp
time
Estimated
blood loss
(mL)
LOS
(days) Mini-incision
(min) (mL) (days) (cm)
otally robotic
(n  5)
60 200 6.6 None
obotic-assisted
(n  15)
89.5 1474.4 11.7 13
utcomes of EVAR in Hemodynamically Stable and Unstable Patients
ith Ruptured AAA: A Prospective Analysis
anish Mehta, MD, MPH, Sean P. Roddy, MD, Yaron Sternbach, MD,
ohn B. Taggert, MD, Paul B. Kreienberg, MD, Philip S.K. Paty, MD,
athleen J. Ozsvath, MD, Benjamin B. Chang, MD, Dhiraj M. Shah, MD,
. Clement Darling III, MD, Albany Medical College/Albany Medical
enter Hospital, Albany, NY.
Objectives: To date there are no published reports comparing hemo-
ynamically (Hd) stable and Hd unstable patients with ruptured abdominal
ortic aneurysms (r-AAA) undergoing endovascular aneurysm repair
EVAR). This study evaluated outcomes of EVAR for r-AAA based on
atient hemodynamic status
Methods: From 2002 to 2009, 106 patients with r-AAA were catego-
ized into two groups based on systolic blood pressure (SBP) measurements
efore EVAR: Hd-stable (SBP 80 mm Hg; n  72, 68%), and Hd-unstable
SBP 80 mm Hg; n  34, 32%). All data were prospectively collected, and
tatistical analysis was performed using 2 square and life-table methods
Results: Of the 106 r-AAA patients with EVAR, the Hd-stable and
d-unstable groups had similar comorbidities (coronary artery disease: 63%
s 59%, hypertension: 72% vs 75%, chronic obstructive pulmonary disease:
1% vs. 26%, and chronic renal insufficienc: 18% vs 18%), the need for
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Volume 53, Number 2 Abstracts 555“on-table” conversion to open surgical repair (2.8% vs 5.9%), the incidence
of nonfatal complications (37% vs 41%), and secondary interventions (26% vs
24%). Hd-unstable patients had a significantly higher incidence of develop-
ing abdominal compartment syndrome ([ACS] 29.4% vs 4.2%, P .05), and
death (Table). ACS had a significant impact on mortality (death with ACS:
62%; death without ACS: 11%, P  .05).
Conclusions: EVAR for r-AAA is feasible in both Hd-stable and
Hd-unstable patients. Hd-stable patients have a short-term and long-term
survival advantage, a lower incidence of ACS, and there is no difference in
the incidence for conversion to open surgical repair, nonfatal complications,
or the need for secondary interventions. Lowering the incidence of ACS
might have an impact on improving survival in Hd-unstable patients.
Table.
Variable Hd-stable Hd-unstable P
Mean AAA size, cm 6.4 6.6 NS
Preoperative CTA 70 (97.2%) 21 (61.8%) .05
ACS 3 (4.2%) 10 (29.4%) .05
30-day mortality 8 (9.7%) 11 (32.2%) .05
Survival at .05
1 year 88% 65%
2 years 79% 54%
3 years 71% 41%
Clinical Relevance of Serial CT Scans in Post-Endovascular Aneurysm
Repair Patients
Elizabeth L. Detschelt, MD,1 Victoria Y. Lee, MD,1 Joseph L. Grisafi,
MD,2 Marissa Toma,3 Daniel H. Benckart, MD,1 Satish C. Muluk, MD,1
1Allegheny General Hospital, Pittsburgh; 2Albert Einstein Medical Center,
Philadelphia; and 3Drexel University College of Medicine, Philadelphia, Pa.
Objective: This study examined the incidence of new clinically signif-
icant incidental (CSI) and endovascular aortic aneurysm repair (EVAR)-
related findings seen on CT scans during long-term follow-up to identify
demographic and clinical predictors of these findings.
Methods: We retrospectively reviewed 915 patients who underwent
EVAR at our institution between December 1, 1999, and November 30,
2009. A total of 608 patients who had an initial repair and had available
preoperative and postoperative CT scan reports defined the study popula-
tion. CSI and EVAR-related findings, demographic, and clinical variables
were recorded. Time course analysis of detection of new findings, and
univariate and multivariate analyses of predictors were performed.
Results: We reviewed 2965 CT scans. There was a median of four
(range, 2-16) CT scans and 32 months (range, 1-121 months) of follow-up
per patient. Overall detection of new CSI findings was 21%. Annual rate of
detection ranged from 14% to 32% over 9.5 years. Annual rate of detection
of EVAR-related findings ranged from 2% to 5% over the first 6 years and was
zero thereafter. Age65 years (P .024), glomerular filtration rate (GFR)
60 (P  .002), and body mass index 22 (P  .019) were predictors of
detecting new findings on univariate analysis. On multivariate analysis age
and GFR remained significant; tobacco use (P .015) was also a predictor.
No predictors were identified for EVAR -related findings.
Conclusions: NewCSI findings were detected at a constant rate on CT
scans obtained for post-EVAR follow-up over 10 years. EVAR-related
findings were detected at a constant rate up to 6 years after the procedure
and then were no longer detected. Patients with older age, renal impairment,
and tobacco use had more CSI findings. Our data suggest that (1) CT scan
may not be necessary for follow-up of EVAR patients after 6 years, and (2)
CT is more likely to detect a CSI finding that warrants further work-up than
a problem with the endograft. These findings are especially relevant as the
risks from repeated CT scans are being highlighted.
Single-Center Experience of Anticoagulation Therapy in Deep Venous
Thromboembolism Patients: Different Treatment Patterns?
Munier M. Nazzal, MD, Weikai Qu, MD, PhD, Mohamed Fedaly, MD,
Jihad Abbas, MD, Gerald Zelenock, MD, University of Toledo, School of
Medicine, Toledo, Ohio.
Objective: The optimal duration of anticoagulation therapy for deep
venous thromboembolism (DVT) is still under debate. The objective of our
study was to compare the outcome of anticoagulation treatment in DVT
patients by vascular surgeons (VS) and primary care physicians (PCP) and
analyze the underlying reasons that cause the differences.
Methods: Medical records of 485 DVT patients treated at our center
from 2000 to 2007 were retrospectively reviewed. Demographic data and
information about risk factors, site of DVT, length of anticoagulation
therapy, clot resolution rate monitored by ultrasound (US) imaging follow-
ups, and complications related to treatments were collected. Statistic analysis
E
cas conducted with SPSS 17.0 software. The 2 test or Fisher exact test was
sed for categoric data, and the Student t test was used for continuous data.
 .05 was considered statistically significant.
Results: Of the 485 patients, 122 were treated by VS and 363 were
reated by PCP. There were no significant differences in age, gender,
reexisting risk factors, and incidences of complications between two
roups. However, the VS group had a significantly higher US imaging
ollow-up rate (73% vs 47.1%, P  .0001), longer anticoagulation therapy
uration (P .03), and better clot resolution rate (P .009) than the PCP
roup (Table). Further analysis demonstrates a significant difference in the
ength of anticoagulation therapy between patients with or without US
enous tests. Forty-eight percent of patients without a US test received 3
onths treatment vs 52% patients with US test received  6 months of
nticoagulant treatment (P  .0001).
Conclusions: Venous US tests can provide valuable information dur-
ng the anticoagulation therapy in DVT patients. The optimal length of
nticoagulation treatment should be adjusted based on the US findings to
mprove the outcome of DVT management and avoid dangerous complica-
ions. The results in our study clearly show that VS use US follow-up in DVT
atients more than PCP and thus have better resolution rates of the clots and
onger period of Coumadin treatment.
able. Length of anticoagulation therapy and clot
esolution rate in different groups
Variable
Length of
anticoagulation
therapy (% of
patients)a
Clot resolution rate in US
follow-ups (% of patients)b
3
mon
3-6
mon
6
mon
No
change
Partial
resolution
Complete
resolution
ascular
surgeon
23.4 22.3 54.3 12.4 25.8 61.8
rimary care
physician
39.1 18.8 42.1 28.7 24.6 46.8
P  .03;
P  .009.
rocedural Factors Influencing the Incidence of Endovenous Heat-
nduced Thrombus (EHIT)
oo J. Rhee, MD, Julianne Stoughton, MD, Nancy L. Cantelmo, MD,
einSolutions, Stoneham, Mass.
Objectives: Endothermal ablation (ETA) has been shown to effectively
reat superficial venous reflux. Endothermal heat-induced thrombosis
EHIT) from the great saphenous vein (GSV) up to or into the common
emoral vein (CFV) has been reported as an early postprocedural complica-
ion of ETA. Our objective was to determine whether procedural factors
nfluence the incidence of EHIT.
Methods: From 2007 to 2009, 878 endothermal ablation procedures,
omprising 482 endovenous laser ablation (ELA), and 396 radiofrequency
blation (RFA), were performed in a single office practice to treat superficial
enous reflux. A retrospective review was performed of ultrasound images
nd patient records. Ultrasound images showing the position of the catheter
ip in relation to the saphenofemoral junction (SFJ) were available for 519
rocedures and were reviewed by independent evaluator. There were 234
LAs (45%) and 285 RFAs (55%). The distance between the tip of the
atheter and the SFJ was measured. Duplex ultrasound imaging was per-
ormed a mean of 2 days (range, 1-8 days) postprocedure.
Results: Of the 519 procedures, duplex ultrasound identified 21
4.0%) with extension of thrombus towards the femoral vein; of these 15
HITs occurred after ELA (6.4%) and 6 after RFA (2.1%; P  .02). There
as no difference in the mean (SD) distance of the catheter tip from the SFJ
etween the EHIT and non-EHIT groups (2.3 [0.5] cm, P  NS). The
ean (SD) diameter of the treated vein was similar (EHIT, 7.9 [2.3] mm,
on-EHIT, 7.8 [3.1] mm; P  NS). There was no difference in the EHIT
nd non-EHIT groups in concomitant thermal ablation of an additional
eins (14% vs 17%, P  NS), ambulatory phlebectomy (86% vs 90%, P 
S), or use of sclerotherapy of incompetent perforators and/or tributaries
19% vs 9%, P .13). The immediate postprocedure closure rate was 99.6%.
Conclusions: EHIT occurred more frequently after ELA than RFA.
here was no difference in catheter tip position or mean diameter of the
reated vein between the EHIT and non-EHIT groups. The concomitant
reatment of additional veins with ETA and/or microphlebectomy was
qual between the two groups. EHITs were found more commonly after
TA in combination with sclerotherapy, but this difference was not statisti-
ally significant.
